Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 10(10): e0140416, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26462203

RESUMEN

Hispaniola, comprising Haiti and the Dominican Republic, has been identified as a candidate for malaria elimination. However, incomplete surveillance data in Haiti hamper efforts to assess the impact of ongoing malaria control interventions. Characteristics of the genetic diversity of Plasmodium falciparum populations can be used to assess parasite transmission, which is information vital to evaluating malaria elimination efforts. Here we characterize the genetic diversity of P. falciparum samples collected from patients at seven sites in Haiti using 12 microsatellite markers previously employed in population genetic analyses of global P. falciparum populations. We measured multiplicity of infections, level of genetic diversity, degree of population geographic substructure, and linkage disequilibrium (defined as non-random association of alleles from different loci). For low transmission populations like Haiti, we expect to see few multiple infections, low levels of genetic diversity, high degree of population structure, and high linkage disequilibrium. In Haiti, we found low levels of multiple infections (12.9%), moderate to high levels of genetic diversity (mean number of alleles per locus = 4.9, heterozygosity = 0.61), low levels of population structure (highest pairwise Fst = 0.09 and no clustering in principal components analysis), and moderate linkage disequilibrium (ISA = 0.05, P<0.0001). In addition, population bottleneck analysis revealed no evidence for a reduction in the P. falciparum population size in Haiti. We conclude that the high level of genetic diversity and lack of evidence for a population bottleneck may suggest that Haiti's P. falciparum population has been stable and discuss the implications of our results for understanding the impact of malaria control interventions. We also discuss the relevance of parasite population history and other host and vector factors when assessing transmission intensity from genetic diversity data.


Asunto(s)
Variación Genética , Repeticiones de Microsatélite/genética , Plasmodium falciparum/genética , Alelos , Frecuencia de los Genes/genética , Geografía , Haití , Heterocigoto , Humanos , Desequilibrio de Ligamiento/genética , Malaria Falciparum/parasitología , Dinámica Poblacional , Análisis de Componente Principal , Tamaño de la Muestra
2.
Am J Trop Med Hyg ; 91(2): 412-4, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24891465

RESUMEN

Haiti is one of two remaining malaria-endemic countries in the Caribbean. To decrease malaria transmission in Haiti, primaquine was recently added to the malaria treatment public health policy. One limitation of primaquine is that, at certain doses, primaquine can cause hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PDd). In this study, we genotyped two mutations (A376G and G202A), which confer the most common G6PDd variant in West African populations, G6PDd A-. We estimated the frequency of G6PDd A- in a sample of febrile patients enrolled in an on-going malaria study who represent a potential target population for a primaquine mass drug administration. We found that 33 of 168 individuals carried the G6PDd A- allele (includes A- hemizygous males, A- homozygous or heterozygous females) and could experience toxicity if treated with primaquine. These data inform discussions on safe and effective primaquine dosing and future malaria elimination strategies for Haiti.


Asunto(s)
Alelos , Anemia Hemolítica/prevención & control , Fiebre/genética , Deficiencia de Glucosafosfato Deshidrogenasa/genética , Glucosafosfato Deshidrogenasa/genética , Malaria Falciparum/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anemia Hemolítica/etiología , Antimaláricos/administración & dosificación , Niño , Preescolar , Contraindicaciones , Femenino , Fiebre/complicaciones , Fiebre/tratamiento farmacológico , Fiebre/enzimología , Genotipo , Glucosafosfato Deshidrogenasa/metabolismo , Deficiencia de Glucosafosfato Deshidrogenasa/complicaciones , Deficiencia de Glucosafosfato Deshidrogenasa/tratamiento farmacológico , Deficiencia de Glucosafosfato Deshidrogenasa/enzimología , Haití , Heterocigoto , Homocigoto , Humanos , Lactante , Malaria Falciparum/complicaciones , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/enzimología , Masculino , Persona de Mediana Edad , Mutación , Primaquina/administración & dosificación
3.
Am J Trop Med Hyg ; 91(2): 406-11, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24957539

RESUMEN

Sickle cell disease is a growing global health concern because infants born with the disorder in developing countries are now surviving longer with little access to diagnostic and management options. In Haiti, the current state of sickle cell disease/trait in the population is unclear. To inform future screening efforts in Haiti, we assayed sickle hemoglobin mutations using traditional hemoglobin solubility tests (HST) and add-on techniques, which incorporated spectrophotometry and insoluble hemoglobin separation. We also generated genotype data as a metric for HST performance. We found 19 of 202 individuals screened with HST were positive for sickle hemoglobin, five of whom did not carry the HbS allele. We show that spectrophotometry and insoluble hemoglobin separation add-on techniques could resolve false positives associated with the traditional HST approach, with some limitations. We also discuss the incorporation of insoluble hemoglobin separation observation with HST in suboptimal screening settings like Haiti.


Asunto(s)
Anemia de Células Falciformes/diagnóstico , Genotipo , Hemoglobina Falciforme/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Alelos , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/genética , Niño , Preescolar , Frecuencia de los Genes , Técnicas de Genotipaje , Hemoglobina Falciforme/química , Hemoglobina Falciforme/aislamiento & purificación , Humanos , Lactante , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Solubilidad , Espectrofotometría
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA